Suchergebnisse - Dahl, Viktor
- Treffer 1 - 15 von 15
-
1
-
2
-
3
-
4
-
5
Lyme neuroborreliosis epidemiology in Sweden 2010 to 2014: clinical microbiology laboratories are a better data source than the hospital discharge diagnosis register von Dahl, Viktor, Wisell, Karin T, Giske, Christian G, Tegnell, Anders, Wallensten, Anders
Veröffentlicht 2019Text -
6
Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation von Dahl, Viktor, Peterson, Julia, Fuchs, Dietmar, Gisslen, Magnus, Palmer, Sarah, Price, Richard W.
Veröffentlicht 2014Text -
7
-
8
-
9
Searching for unknown transfusion-transmitted hepatitis viruses: a bi-national cohort study of 1.5 million transfused patients von Edgren, Gustaf, Hjalgrim, Henrik, Rostgaard, Klaus, Dahl, Viktor, Titlestad, Kjell, Erikstrup, Christian, Wikman, Agneta, Norda, Rut, Majeed, Ammar
Veröffentlicht 2018Text -
10
Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy von Dahl, Viktor, Lee, Evelyn, Peterson, Julia, Spudich, Serena S., Leppla, Idris, Sinclair, Elizabeth, Fuchs, Dietmar, Palmer, Sarah, Price, Richard W.
Veröffentlicht 2011Text -
11
A nationwide outbreak of listeriosis associated with cold-cuts, Sweden 2013-2014 von Dahl, Viktor, Sundqvist, Lena, Hedenström, Ingela, Löfdahl, Margareta, Alm, Erik, Ringberg, Håkan, Lindblad, Mats, Wallensten, Anders, Thisted Lambertz, Susanne, Jernberg, Cecilia
Veröffentlicht 2017Text -
12
A Randomized, Controlled Trial of Raltegravir Intensification in Antiretroviral-treated, HIV-infected Patients with a Suboptimal CD4(+) T Cell Response von Hatano, Hiroyu, Hayes, Timothy L., Dahl, Viktor, Sinclair, Elizabeth, Lee, Tzong-Hae, Hoh, Rebecca, Lampiris, Harry, Hunt, Peter W., Palmer, Sarah, McCune, Joseph M., Martin, Jeffrey N., Busch, Michael P., Shacklett, Barbara L., Deeks, Steven G.
Veröffentlicht 2011Text -
13
Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected von Gutiérrez, Carolina, Díaz, Laura, Vallejo, Alejandro, Hernández-Novoa, Beatriz, Abad, María, Madrid, Nadia, Dahl, Viktor, Rubio, Rafael, Moreno, Ana M., Dronda, Fernando, Casado, José Luis, Navas, Enrique, Pérez-Elías, María Jesús, Zamora, Javier, Palmer, Sarah, Muñoz, Eduardo, Muñoz-Fernández, María Ángeles, Moreno, Santiago
Veröffentlicht 2011Text -
14
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial von Hunt, Peter W., Shulman, Nancy S., Hayes, Timothy L., Dahl, Viktor, Somsouk, Ma, Funderburg, Nicholas T., McLaughlin, Bridget, Landay, Alan L., Adeyemi, Oluwatoyin, Gilman, Lee E., Clagett, Brian, Rodriguez, Benigno, Martin, Jeffrey N., Schacker, Timothy W., Shacklett, Barbara L., Palmer, Sarah, Lederman, Michael M., Deeks, Steven G.
Veröffentlicht 2013Text -
15
Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies von Eriksson, Susanne, Graf, Erin H., Dahl, Viktor, Strain, Matthew C., Yukl, Steven A., Lysenko, Elena S., Bosch, Ronald J., Lai, Jun, Chioma, Stanley, Emad, Fatemeh, Abdel-Mohsen, Mohamed, Hoh, Rebecca, Hecht, Frederick, Hunt, Peter, Somsouk, Ma, Wong, Joseph, Johnston, Rowena, Siliciano, Robert F., Richman, Douglas D., O'Doherty, Una, Palmer, Sarah, Deeks, Steven G., Siliciano, Janet D.
Veröffentlicht 2013Text